ArticleHealthcare technology letters2024
A related convolutional neural network for cancer diagnosis using microRNA data classification.
Article in Healthcare technology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A related convolutional neural network for cancer diagnosis using microRNA data classification.Healthcare technology letters · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper develops a method for cancer classification from microRNA data using a convolutional neural network (CNN)-based model optimized by genetic algorithm. The convolutional neural network has performed well in various recognition and perception tasks. This paper contributes to the cancer classification using a union of two CNNs. The method's performance is boosted by the relationship between CNNs and exchanging knowledge between them. Besides, communication between small sizes of CNNs reduces the need for large size CNNs and, consequently, the computational time and memory usage while preserving high accuracy. The method proposed is tested on microRNA dataset containing the genomic information of 8129 patients for 29 different types of cancer with 1046 gene expression. The classification accuracy of the selected genes obtained by the proposed approach is compared with the accuracy of 22 well-known classifiers on a real-world dataset. The classification accuracy of each cancer type is also ranked with the results of 77 classifiers reported in previous works. The proposed approach shows accuracy of 100% in 24 out of 29 classes and in seven cases out of 29, the method achieved 100% accuracy that no classifier in other studies has reached. Performance analysis is performed using performance metrics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.